Michalski, C. W. Et Al. 2008. Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer. BRITISH JOURNAL OF CANCER , vol.99, no.5 , 760-767.

Michalski, C. W., Erkan, M. M., Sauliunaite, D., Giese, T., Stratmann, R., Sartori, C., ... Giese, N. A.(2008). Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer. BRITISH JOURNAL OF CANCER , vol.99, no.5, 760-767.

Michalski, C. Et Al. "Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer," BRITISH JOURNAL OF CANCER , vol.99, no.5, 760-767, 2008

Michalski, C. W. Et Al. "Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer." BRITISH JOURNAL OF CANCER , vol.99, no.5, pp.760-767, 2008

Michalski, C. W. Et Al. (2008) . "Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer." BRITISH JOURNAL OF CANCER , vol.99, no.5, pp.760-767.

@article{article, author={C. W. Michalski Et Al. }, title={Ex vivo chemosensitivity testing and gene expression profiling predict response towards adjuvant gemcitabine treatment in pancreatic cancer}, journal={BRITISH JOURNAL OF CANCER}, year=2008, pages={760-767} }